(NYSE: ALUR) Allurion Technologies's forecast annual revenue growth rate of 15.69% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.85%.
Allurion Technologies's revenue in 2025 is $28,304,000.On average, 3 Wall Street analysts forecast ALUR's revenue for 2025 to be $213,537,985, with the lowest ALUR revenue forecast at $194,647,484, and the highest ALUR revenue forecast at $223,732,740. On average, 3 Wall Street analysts forecast ALUR's revenue for 2026 to be $318,446,267, with the lowest ALUR revenue forecast at $241,631,359, and the highest ALUR revenue forecast at $391,532,295.
In 2027, ALUR is forecast to generate $279,665,925 in revenue, with the lowest revenue forecast at $279,665,925 and the highest revenue forecast at $279,665,925.